Live Breaking News & Updates on Chairman Neil Desai

Stay updated with breaking news from Chairman neil desai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aadi Bioscience, Inc. (NASDAQ:AADI) Sees Significant Increase in Short Interest

Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) was the recipient of a large growth in short interest in November. As of November 30th, there was short interest totalling 789,000 shares, a growth of 6.1% from the November 15th total of 743,700 shares. Currently, 4.6% of the company’s stock are sold short. Based on an […] ....

Neil Desai , Aadi Bioscience , Piper Sandler , Group Plc , Citigroup Inc , Securities Exchange Commission , Royal Bank , Aadi Bioscience Company Profile , Barclays Plc , Aadi Bioscience Inc , Get Free Report , Chairman Neil Desai , Exchange Commission , General Group Plc , Aadi Bioscience Daily , Nasdaq Aadi ,

Aadi Bioscience, Inc. (NASDAQ:AADI) Chairman Neil Desai Sells 7,037 Shares

Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 7,037 shares of the stock in a transaction that occurred on Wednesday, December 6th. The shares were sold at an average price of $4.82, for a total value of $33,918.34. Following the sale, the chairman now owns 1,537,543 shares of the company’s stock, […] ....

Knott Davidm Jr , Neil Desai , Aadi Bioscience , Aadi Bioscience Inc , Ghost Tree Capital , Royal Bank , Aadi Bioscience Company Profile , Get Free Report , Chairman Neil Desai , Montreal Can , Point Capital Management , Tree Capital , Aadi Bioscience Daily , Nasdaq Aadi , Insider Trading , Nsider Trades ,

Neil Desai Sells 7,037 Shares of Aadi Bioscience, Inc. (NASDAQ:AADI) Stock

Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 7,037 shares of the stock in a transaction on Wednesday, December 6th. The shares were sold at an average price of $4.82, for a total value of $33,918.34. Following the completion of the sale, the chairman now owns 1,537,543 shares in the company, […] ....

Neil Desai , Aadi Bioscience , Schonfeld Strategic Advisors , Cubist Systematic Strategies , Tower Research Capital , Aadi Bioscience Inc , Group Plc , Aadi Bioscience Company Profile , Jpmorgan Chase Co , Get Free Report , Chairman Neil Desai , Research Capital , Strategic Advisors , Systematic Strategies , General Group Plc , Aadi Bioscience Daily , Nasdaq Aadi , Insider Trading , Nsider Trades ,

Aadi Bioscience, Inc. (NASDAQ:AADI) Chairman Sells $42,903.58 in Stock

Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 8,347 shares of the business’s stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $5.14, for a total transaction of $42,903.58. Following the completion of the sale, the chairman now owns 1,571,196 shares in the […] ....

Neil Desai , Aadi Bioscience , Aadi Bioscience Inc , Aadi Bioscience Company Profile , Citigroup Inc , Securities Exchange Commission , Royal Bank , Barclays Plc , Group Plc , Get Free Report , Chairman Neil Desai , Exchange Commission , General Group Plc , Aadi Bioscience Daily , Nasdaq Aadi , Insider Trading , Nsider Trades ,

Insider Selling: Aadi Bioscience, Inc. (NASDAQ:AADI) Chairman Sells 10,338 Shares of Stock

Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 10,338 shares of the business’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $4.32, for a total transaction of $44,660.16. Following the completion of the transaction, the chairman now owns 1,611,205 shares in the […] ....

Aadi Bioscience , Neil Desai , Aadi Bioscience Inc , Group Plc , Royal Bank , Barclays Plc , Citigroup Inc , Get Free Report , Chairman Neil Desai , General Group Plc , Aadi Bioscience Daily , Nasdaq Aadi , Insider Trading , Nsider Trades ,